Transcriptome Analysis Reveals AI-2 Relevant Genes of Multi-Drug Resistant Klebsiella Pneumoniae in Response to Eugenol at Sub-Mic

Frontiers in Microbiology - Switzerland
doi 10.3389/fmicb.2019.01159
Full Text
Abstract

Available in full text

Categories
Microbiology
Date
Authors
Publisher

Frontiers Media SA

Related search

Genetic Features of Multi Drug Resistant (MDR) Klebsiella Pneumoniae and Its Plasmids

2019English

Analysis of the Drug-Resistant Characteristics of Klebsiella Pneumoniae Isolated From the Respiratory Tract and CTX-M ESBL Genes

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

Dissemination of Extensively Drug-Resistant and KPC-2 Producing Klebsiella Pneumoniae Isolated From Bloodstream Infections

Journal of Infection in Developing Countries
MedicineVirologyParasitologyInfectious DiseasesMicrobiology
2015English

Phenotypic and Genotypic Diversity of Nosocomial Multi-Drug Resistant Klebsiella Pneumoniae Isolated From Cancer Patients in Cairo, Egypt

International Journal of Current Microbiology and Applied Sciences
2016English

Extensively Drug-Resistant Klebsiella Pneumoniae ST307 Outbreak, North-Eastern Germany, June to October 2019

Eurosurveillance
EnvironmentalVirologyPublic HealthEpidemiologyMedicineOccupational Health
2019English

Whole Genome Sequencing Snapshot of Multi-Drug Resistant Klebsiella Pneumoniae Strains From Hospitals and Receiving Wastewater Treatment Plants in Southern Romania

PLoS ONE
Multidisciplinary
2020English

Nacubactam Enhances Meropenem Activity Against Carbapenem-Resistant Klebsiella Pneumoniae Producing Klebsiella Pneumoniae Carbapenemases (KPC)

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Genomic Comparison Reveals Natural Occurrence of Clinically Relevant Multi-Drug Resistant Extended-Spectrum Β-Lactamase Producing Escherichia Coli

Applied and Environmental Microbiology
Applied MicrobiologyBiotechnologyEcologyFood Science
2019English

Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line

Frontiers in Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy